We are live on ! Find out more
SCM

Summit Capital Management Portfolio holdings

AUM $221M
1-Year Est. Return 4.14%
This Fund
S&P 500
This Quarter Est. Return
+4.83%
1 Year Est. Return
-4.14%
3 Year Est. Return
+12.39%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$279M
AUM Growth
-$4.24M
Cap. Flow
-$15.4M
Cap. Flow %
-5.51%
Top 10 Hldgs %
47.81%
Holding
72
New
10
Increased
17
Reduced
21
Closed
17

Top Buys

Rank Stock Value
1
EWI icon
iShares MSCI Italy ETF
EWI
+$9.69M
2
XTN icon
State Street SPDR S&P Transportation ETF
XTN
+$5.11M
3
PCH
PotlatchDeltic
PCH
+$4.87M
4
LFCR icon
Lifecore Biomedical
LFCR
+$3.48M
5
VOD icon
Vodafone
VOD
+$2.97M

Top Sells

Rank Stock Value
1
IBB icon
iShares Biotechnology ETF
IBB
+$9.07M
2
PSA.PRR
PUBLIC STORAGE DEPOSITORY SH REPSTG 1/1000TH PFD SER R
PSA.PRR
+$7.54M
3
PM icon
Philip Morris
PM
+$5.92M
4
TAN icon
Invesco Solar ETF
TAN
+$5.15M
5
PJP icon
Invesco Pharmaceuticals ETF
PJP
+$4.35M

Sector Composition

Rank Sector Weight
1 Industrials 14.91%
2 Energy 13.37%
3 Technology 10.37%
4 Real Estate 10.36%
5 Healthcare 9.6%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DVY icon
51
iShares Select Dividend ETF
DVY
$23.6B
$303K 0.11%
+3,932
New +$294K
BAC icon
52
Bank of America
BAC
$440B
$257K 0.09%
16,737
+2,000
+14% +$31.1K
TSYS
53
DELISTED
TELECOMMUNICATIONS SYS INC "A"
TSYS
$99K 0.04%
30,000
– –
WYY icon
54
WidePoint Corp
WYY
$111M
$35K 0.01%
2,000
+1,000
+100% +$14.9K
EFC
55
Ellington Financial
EFC
$1.72B
– –
-115,000
Closed -$2.74M
GLD icon
56
SPDR Gold Trust
GLD
$141B
– –
-8,045
Closed -$994K
IBB icon
57
iShares Biotechnology ETF
IBB
$9.65B
– –
-115,164
Closed -$9.07M
NEM icon
58
Newmont
NEM
$119B
– –
-43,950
Closed -$1.03M
PM icon
59
Philip Morris
PM
$295B
– –
-72,355
Closed -$5.92M
SIRI icon
60
SiriusXM
SIRI
$10B
– –
-1,000
Closed -$32K
TAN icon
61
Invesco Solar ETF
TAN
$1.49B
– –
-116,515
Closed -$5.15M
TBT icon
62
ProShares Trust UltraShort Lehman 20+ Year Treasury
TBT
$313M
– –
-36,012
Closed -$2.43M
UEC icon
63
Uranium Energy
UEC
$5.58B
– –
-21,150
Closed -$28K
VZ icon
64
Verizon
VZ
$195B
– –
-5,554
Closed -$264K
EMAN
65
DELISTED
eMagin Corporation
EMAN
– –
-10,000
Closed -$25K
MDR
66
DELISTED
McDermott International
MDR
– –
-40,917
Closed -$960K
XCO
67
DELISTED
Exco Resources
XCO
– –
-733
Closed -$62K
RGDX
68
DELISTED
RESPONSE GENETICS, INC COMMON SHS (DELAWARE)
RGDX
– –
-10,000
Closed -$12K
FST
69
DELISTED
FOREST OIL CORPORATION
FST
– –
-21,000
Closed -$40K
KIOR
70
DELISTED
KIOR, INC CLASS A COM STK
KIOR
– –
-20,000
Closed -$11K
PSA.PRR
71
DELISTED
PUBLIC STORAGE DEPOSITORY SH REPSTG 1/1000TH PFD SER R
PSA.PRR
– –
-298,874
Closed -$7.54M
1 2
3

Similar funds

PCM
Prosiris Capital Management New York $219M AUM 11.3% 1-Year Est. Return
ACM
Andor Capital Management Rye Brook, New York $232M AUM 22.72% 1-Year Est. Return
SHG
Seven Harbour Global New York $235M AUM
HF
Hoxton Financial Shepherdstown, West Virginia $194M AUM 6.21% 1-Year Est. Return
SAS
Spectrum Advisory Services Atlanta, Georgia $255M AUM 4.81% 1-Year Est. Return
WI
WHV Investments San Francisco, California $187M AUM 14.29% 1-Year Est. Return
SRCM
Sterling Ridge Capital Management New York $158M AUM 7.07% 1-Year Est. Return
CGH
Cleary Gull Holdings Milwaukee, Wisconsin $148M AUM 6.93% 1-Year Est. Return

Summit Capital Management's Q2 2014 Portfolio in Review

As of Q2 2014, Summit Capital Management held 72 positions worth $279M, down 1.5% from $283M the previous quarter. Its ten largest holdings account for 48% of the portfolio.

Summit Capital Management withdrew a net $15.4M in Q2 2014, closing 17 positions and reducing 21 holdings. Its most notable exit was iShares Biotechnology ETF, an estimated $9.07M position sold in full.

By sector, the portfolio is most concentrated in Industrials at 15% of assets, up from 14% a quarter earlier, followed by Energy and Technology.

Against the trend, Summit Capital Management opened a new position in iShares MSCI Italy ETF worth $9.53M.

  • Summit Capital Management's largest Q2 2014 buy was iShares MSCI Italy ETF: 274,220 shares worth $9.53M.
  • Summit Capital Management added most to PotlatchDeltic in Q2 2014, an estimated $4.87M increase.
  • Summit Capital Management's biggest Q2 2014 reduction was Invesco Pharmaceuticals ETF, cutting an estimated $4.35M.
  • Summit Capital Management fully exited iShares Biotechnology ETF in Q2 2014, selling an estimated $9.07M.
  • Summit Capital Management's ten largest holdings make up 48% of its $279M portfolio in Q2 2014.
  • Summit Capital Management opened 10 new positions and closed 17 in Q2 2014.
  • Summit Capital Management's portfolio value fell 1.5% quarter-over-quarter to $279M.

Based on Summit Capital Management's 13F filing for Q2 2014, filed 8 Aug 2014.